Mental Wellness Program
Bio-Escitalopram escitalopram
Evaluated tools to help you understand your treatment, track what changes and know who to talk to.
Where are you in your treatment?
-
Weeks 1–2
Getting started
-
Weeks 2–6
Feeling the first effects
-
6 weeks and more
Staying on track
-
Any time
Something feels off
Essentials to get started
-
App
Daylio
Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
-
Website
Bounce Back
Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.
-
App
Prezens
Short breathing, meditation and mindfulness exercises to pause and find calm.
Tools by topic
Understand your treatment
How escitalopram works, and what to expect.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Article
Antidepressants, part 2: when and how to stop
When stopping may be considered, how to taper gradually with a professional, and which withdrawal symptoms to watch for.
-
Article
Drugs for treatment of depression
Consumer reference on antidepressant classes, how they act, and their side effects.
-
Podcast
One in Five, with Florence K — Episode 6: Depressive disorders
An artist's first-hand account of depression, her daughter's perspective, and a psychologist's advice for people affected and their loved ones.
-
Video
The black dog of depression
Short WHO animation that portrays depression as a "black dog" and shows that it can be tamed.
Take care of yourself day to day
Therapy, stress management and support, at your own pace.
-
Website
Relief — self-management workshops
10- to 12-week group workshops, online or in person in several Quebec regions, to live better with anxiety, depression or bipolar disorder.
-
Website
Bounce Back
Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.
-
Video
Building connections and being well surrounded
Why social connections protect mental health, with practical ideas to build and keep them.
-
App
Prezens
Short breathing, meditation and mindfulness exercises to pause and find calm.
-
App
MindDay
Daily online coaching based on recognized strategies and mindfulness, to better understand thoughts and emotions.
-
Website
Équilia — CBT and mindfulness program
Free, self-paced 6-lesson online program combining cognitive behavioural therapy and mindfulness. No waiting list.
Track what changes
Note how you feel to see how things evolve, and bring it to your appointments.
-
App
Daylio
Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
Know when to call
What is expected, what should make you call, and who to contact.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Article
Drugs for treatment of depression
Consumer reference on antidepressant classes, how they act, and their side effects.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
Bio-Escitalopram products
Other escitalopram DINs on the market 75
75 products from other manufacturers. If your DIN is in this list, the tools on this page apply to you too.
| DIN | Brand | Manufacturer | Strength | Form | DPD status |
|---|---|---|---|---|---|
| 02434652 | ACH-ESCITALOPRAM | ACCORD HEALTHCARE INC | 10 mg | TABLET | Marketed |
| 02434660 | ACH-ESCITALOPRAM | ACCORD HEALTHCARE INC | 20 mg | TABLET | Marketed |
| 02477734 | AG-ESCITALOPRAM | ANGITA PHARMA INC. | 5 mg | TABLET | Approved, not yet marketed |
| 02477742 | AG-ESCITALOPRAM | ANGITA PHARMA INC. | 10 mg | TABLET | Marketed |
| 02510944 | AG-ESCITALOPRAM TABLETS | ANGITA PHARMA INC. | 10 mg | TABLET | Marketed |
| 02477750 | AG-ESCITALOPRAM | ANGITA PHARMA INC. | 15 mg | TABLET | Approved, not yet marketed |
| 02477769 | AG-ESCITALOPRAM | ANGITA PHARMA INC. | 20 mg | TABLET | Marketed |
| 02510952 | AG-ESCITALOPRAM TABLETS | ANGITA PHARMA INC. | 20 mg | TABLET | Marketed |
| 02295016 | APO-ESCITALOPRAM | APOTEX INC | 10 mg | TABLET | Marketed |
| 02295024 | APO-ESCITALOPRAM | APOTEX INC | 20 mg | TABLET | Marketed |
| 02397331 | AURO-ESCITALOPRAM | AURO PHARMA INC | 5 mg | TABLET | Approved, not yet marketed |
| 02397358 | AURO-ESCITALOPRAM | AURO PHARMA INC | 10 mg | TABLET | Marketed |
| 02397366 | AURO-ESCITALOPRAM | AURO PHARMA INC | 15 mg | TABLET | Approved, not yet marketed |
| 02397374 | AURO-ESCITALOPRAM | AURO PHARMA INC | 20 mg | TABLET | Marketed |
| 02477203 | ESCITALOPRAM | JAMP PHARMA CORPORATION | 5 mg | TABLET | Approved, not yet marketed |
| 02429780 | ESCITALOPRAM | JAMP PHARMA CORPORATION | 10 mg | TABLET | Marketed |
| 02508893 | JAMP ESCITALOPRAM | JAMP PHARMA CORPORATION | 10 mg | TABLET | Marketed |
| 02477181 | ESCITALOPRAM | JAMP PHARMA CORPORATION | 15 mg | TABLET | Approved, not yet marketed |
| 02429799 | ESCITALOPRAM | JAMP PHARMA CORPORATION | 20 mg | TABLET | Marketed |
| 02508907 | JAMP ESCITALOPRAM | JAMP PHARMA CORPORATION | 20 mg | TABLET | Marketed |
| 02466058 | ESCITALOPRAM | JUBILANT GENERICS LIMITED | 10 mg | TABLET | Approved, not yet marketed |
| 02466066 | ESCITALOPRAM | JUBILANT GENERICS LIMITED | 20 mg | TABLET | Approved, not yet marketed |
| 02512653 | KYE-ESCITALOPRAM | KYE PHARMACEUTICALS INC. | 15 mg | TABLET | Marketed |
| 02537400 | RIVA-ESCITALOPRAM | LABORATOIRE RIVA INC. | 5 mg | TABLET | Approved, not yet marketed |
| 02428830 | RIVA-ESCITALOPRAM | LABORATOIRE RIVA INC. | 10 mg | TABLET | Dormant (not currently sold) |
| 02537419 | RIVA-ESCITALOPRAM | LABORATOIRE RIVA INC. | 15 mg | TABLET | Approved, not yet marketed |
| 02428857 | RIVA-ESCITALOPRAM | LABORATOIRE RIVA INC. | 20 mg | TABLET | Dormant (not currently sold) |
| 02263211 | CIPRALEX -5MG | LUNDBECK CANADA INC | 5 mg | TABLET | Approved, not yet marketed |
| 02263238 | CIPRALEX -10MG | LUNDBECK CANADA INC | 10 mg | TABLET | Marketed |
| 02263246 | CIPRALEX -15MG | LUNDBECK CANADA INC | 15 mg | TABLET | Approved, not yet marketed |
| 02263254 | CIPRALEX -20MG | LUNDBECK CANADA INC | 20 mg | TABLET | Marketed |
| 02566885 | M-ESCITALOPRAM | MANTRA PHARMA INC | 5 mg | TABLET | Approved, not yet marketed |
| 02471418 | M-ESCITALOPRAM | MANTRA PHARMA INC | 10 mg | TABLET | Marketed |
| 02566893 | M-ESCITALOPRAM | MANTRA PHARMA INC | 15 mg | TABLET | Approved, not yet marketed |
| 02471426 | M-ESCITALOPRAM | MANTRA PHARMA INC | 20 mg | TABLET | Marketed |
| 02421879 | IPG-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | 5 mg | TABLET | Approved, not yet marketed |
| 02423472 | MAR-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | 5 mg | TABLET | Approved, not yet marketed |
| 02421887 | IPG-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | 10 mg | TABLET | Approved, not yet marketed |
| 02423480 | MAR-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | 10 mg | TABLET | Marketed |
| 02421895 | IPG-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | 15 mg | TABLET | Approved, not yet marketed |
| 02423499 | MAR-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | 15 mg | TABLET | Approved, not yet marketed |
| 02421909 | IPG-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | 20 mg | TABLET | Approved, not yet marketed |
| 02423502 | MAR-ESCITALOPRAM | MARCAN PHARMACEUTICALS INC | 20 mg | TABLET | Marketed |
| 02407418 | MINT-ESCITALOPRAM | MINT PHARMACEUTICALS INC | 10 mg | TABLET | Marketed |
| 02407426 | MINT-ESCITALOPRAM | MINT PHARMACEUTICALS INC | 15 mg | TABLET | Approved, not yet marketed |
| 02407434 | MINT-ESCITALOPRAM | MINT PHARMACEUTICALS INC | 20 mg | TABLET | Marketed |
| 02309467 | MYLAN-ESCITALOPRAM | MYLAN PHARMACEUTICALS ULC | 10 mg | TABLET | Marketed |
| 02309475 | MYLAN-ESCITALOPRAM | MYLAN PHARMACEUTICALS ULC | 20 mg | TABLET | Marketed |
| 02554895 | NATCO-ESCITALOPRAM | NATCO PHARMA (CANADA) INC | 5 mg | TABLET | Approved, not yet marketed |
| 02554909 | NATCO-ESCITALOPRAM | NATCO PHARMA (CANADA) INC | 10 mg | TABLET | Marketed |
| 02554917 | NATCO-ESCITALOPRAM | NATCO PHARMA (CANADA) INC | 15 mg | TABLET | Approved, not yet marketed |
| 02554933 | NATCO-ESCITALOPRAM | NATCO PHARMA (CANADA) INC | 20 mg | TABLET | Marketed |
| 02489163 | NRA-ESCITALOPRAM | NORA PHARMA INC | 5 mg | TABLET | Approved, not yet marketed |
| 02476851 | NRA-ESCITALOPRAM | NORA PHARMA INC | 10 mg | TABLET | Marketed |
| 02489198 | NRA-ESCITALOPRAM | NORA PHARMA INC | 15 mg | TABLET | Approved, not yet marketed |
| 02476878 | NRA-ESCITALOPRAM | NORA PHARMA INC | 20 mg | TABLET | Marketed |
| 02566354 | BALANSYA | ORIMED PHARMA INC | 2 mg | SOLUTION | Marketed |
| 02303949 | PMSC-ESCITALOPRAM | PHARMASCIENCE INC | 10 mg | TABLET | Dormant (not currently sold) |
| 02469243 | PMS-ESCITALOPRAM | PHARMASCIENCE INC | 10 mg | TABLET | Marketed |
| 02303965 | PMSC-ESCITALOPRAM | PHARMASCIENCE INC | 20 mg | TABLET | Dormant (not currently sold) |
| 02469251 | PMS-ESCITALOPRAM | PHARMASCIENCE INC | 20 mg | TABLET | Marketed |
| 02424401 | ESCITALOPRAM | PRO DOC LIMITEE | 10 mg | TABLET | Marketed |
| 02424428 | ESCITALOPRAM | PRO DOC LIMITEE | 20 mg | TABLET | Marketed |
| 02364077 | SANDOZ ESCITALOPRAM | SANDOZ CANADA INCORPORATED | 10 mg | TABLET | Marketed |
| 02364085 | SANDOZ ESCITALOPRAM | SANDOZ CANADA INCORPORATED | 20 mg | TABLET | Marketed |
| 02430118 | ESCITALOPRAM | SANIS HEALTH INC | 10 mg | TABLET | Marketed |
| 02430126 | ESCITALOPRAM | SANIS HEALTH INC | 20 mg | TABLET | Marketed |
| 02429039 | ESCITALOPRAM | SIVEM PHARMACEUTICALS ULC | 10 mg | TABLET | Marketed |
| 02429047 | ESCITALOPRAM | SIVEM PHARMACEUTICALS ULC | 20 mg | TABLET | Marketed |
| 02385481 | SPC-ESCITALOPRAM | SUN PHARMA CANADA INC | 10 mg | TABLET | Marketed |
| 02385503 | SPC-ESCITALOPRAM | SUN PHARMA CANADA INC | 20 mg | TABLET | Marketed |
| 02318180 | TEVA-ESCITALOPRAM | TEVA CANADA LIMITED | 10 mg | TABLET | Marketed |
| 02454297 | ACT ESCITALOPRAM ODT | TEVA CANADA LIMITED | 10 mg | TABLET (ORALLY-DISINTEGRATING) | Marketed |
| 02318202 | TEVA-ESCITALOPRAM | TEVA CANADA LIMITED | 20 mg | TABLET | Marketed |
| 02454300 | ACT ESCITALOPRAM ODT | TEVA CANADA LIMITED | 20 mg | TABLET (ORALLY-DISINTEGRATING) | Marketed |
For pharmacists and healthcare professionals
Every tool was evaluated against public criteria. You can share this page directly with your patients: no DIN is required.